Glutamate transporters (EAATs) play an important role in the regulation of extracellular levels of glutamate, a major excitatory neurotransmitter in the central nervous system. Current data suggest that increased extracellular glutamate concentration is involved in the pathophysiology of ischemic brain injury and several major human neurodegenerative disorders, such as Alzheimer's diseases and amyotrophic lateral sclerosis. Thus, normal functioning of EAATs is important for maintaining efficient neurotransmission and preventing neuronal injury. Our long-term research goals are to understand the regulation of EAATs and their role in the mechanisms of anesthesia, synaptic plasticity and neuroprotection. Volatile anesthetics, such as isoflurane, increase the activity and cell surface expression of EAAT type 3 (EAAT3), the major neuronal EAAT. This effect is protein kinase C (PKC) 1-dependent and relies on the phosphorylation of S465 in EAAT3. Isoflurane also increases the protein expression of EAAT3. This proposal aims to 1) determine whether isoflurane-induced EAAT3 redistribution to the plasma membrane is mediated by increased delivery of EAAT3 from cytosol to the plasma membrane;2) identify proteins involved in the recycling of EAAT3 and determine how phosphorylation of S465 changes the protein-protein interaction to alter the distribution of EAAT3;3) determine the role of S465 phosphorylation-induced EAAT3 redistribution in the formation of long-term potentiation and isoflurane-induced neuroprotection;and 4) identify the mechanisms for isoflurane to increase the EAAT3 expression. Cell cultures, hippocampal slices and intact animals (rats and mice) will be used in the studies. Protein biotinylation and immunoprecipitation will be performed to study EAAT3 trafficking and protein- protein interaction. RNA interference and dominant negative constructs will be used to down-regulate protein expression and functions. Sequence-specific peptide inhibitors will be used to investigate the biological functions of EAAT3 redistribution to the plasma membrane. EAAT3 promoter activity will be assayed in the presence or absence of isoflurane. These studies will provide a molecular basis for the anesthetic regulation of glutamate transport and may suggest new targets for neuroprotection or for regulation of synaptic plasticity.

Public Health Relevance

Isoflurane, a commonly used anesthetic in clinical practice, affects the function and location of glutamate transporters, cellular proteins involved in a broad range of brain functions. This project is designed to investigate how isoflurane regulates the function and location of these proteins and the biological consequences of these regulations, such as providing brain adaptation and protection. These studies may help understand how isoflurane works to cause its biological effects, such as brain protection, and also may suggest novel methods to induce these effects.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM065211-08
Application #
7825254
Study Section
Special Emphasis Panel (ZRG1-SBIB-E (04))
Program Officer
Cole, Alison E
Project Start
2002-04-01
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
8
Fiscal Year
2010
Total Cost
$290,221
Indirect Cost
Name
University of Virginia
Department
Anesthesiology
Type
Schools of Medicine
DUNS #
065391526
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Wan, Li; Bi, Jiangjiang; Li, Jun et al. (2017) Glutamate transporter type 3 participates in maintaining morphine-induced conditioned place preference. Neuroscience 344:67-73
Tan, Hongying; Bi, Jiangjiang; Wang, Yunzhen et al. (2015) Transfusion of Old RBCs Induces Neuroinflammation and Cognitive Impairment. Crit Care Med 43:e276-86
Wang, Zhi; Li, Liaoliao; Zhao, Huijuan et al. (2015) Chronic high fat diet induces cardiac hypertrophy and fibrosis in mice. Metabolism 64:917-25
Wang, Zhi; Feng, Chenzhuo; Zhao, Huijuan et al. (2015) Autoregulation of inducible nitric oxide synthase expression by RNA interference provides neuroprotection in neonatal rats. Theranostics 5:504-14
Deng, Jiao; Xiong, Lize; Zuo, Zhiyi (2015) Trans-sodium crocetinate provides neuroprotection against cerebral ischemia and reperfusion in obese mice. J Neurosci Res 93:615-22
Zhang, Junfeng; Tan, Hongying; Jiang, Wei et al. (2015) The choice of general anesthetics may not affect neuroinflammation and impairment of learning and memory after surgery in elderly rats. J Neuroimmune Pharmacol 10:179-89
Ren, Xiaoyan; Wang, Zhi; Ma, Hong et al. (2014) Sevoflurane postconditioning provides neuroprotection against brain hypoxia-ischemia in neonatal rats. Neurol Sci 35:1401-4
Feng, Chenzhuo; Zhang, Ying; Yin, Jinbo et al. (2014) Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma. Neuro Oncol 16:1078-85
Zhang, Junfeng; Tan, Hongying; Jiang, Wei et al. (2014) Amantadine alleviates postoperative cognitive dysfunction possibly by increasing glial cell line-derived neurotrophic factor in rats. Anesthesiology 121:773-85
Yin, Jinbo; Li, Hong; Feng, Chenzhuo et al. (2014) Inhibition of brain ischemia-caused notch activation in microglia may contribute to isoflurane postconditioning-induced neuroprotection in male rats. CNS Neurol Disord Drug Targets 13:718-32

Showing the most recent 10 out of 91 publications